Optovue announced FDA clearance and immediate U.S. commercial availability of the AngioVue™ Imaging System, a groundbreaking technology that provides a non-invasive way to visualize abnormal blood vessels in the retina to help physicians determine an appropriate course of treatment.
The AngioVue System, with its proprietary technology, provides physicians with a non-invasive, dyeless technique for quickly visualizing the presence or absence of flow in the blood vessels.
This enables the assessment of new information from the microvasculature and perfusion in ocular diseases with extraordinary detail.
